Makers of GLP-1 drugs ordered to add warnings about rare eye condition that can lead to blindness
Editorial abstract
The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.
This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.Story classification
Topics
War, Deterrence, and Regional Escalation · High confidence · AutomaticStory-text match
Regions
Global · Low confidence · AutomaticBroad source default; editorial correction recommended